APA (7th ed.) Citation

L, A., KM, B., H, D., SH, M., D, P., & J, D. (2024). The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma. Seminars in oncology nursing, 40(2), 151614. https://doi.org/10.1016/j.soncn.2024.151614

Chicago Style (17th ed.) Citation

L, Andersen, Baker KM, Difilippo H, Meghani SH, Porter D, and Deng J. "The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma." Seminars in Oncology Nursing 40, no. 2 (2024): 151614. https://doi.org/10.1016/j.soncn.2024.151614.

MLA (9th ed.) Citation

L, Andersen, et al. "The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for Lymphoma." Seminars in Oncology Nursing, vol. 40, no. 2, 2024, p. 151614, https://doi.org/10.1016/j.soncn.2024.151614.